- Home
- MATV vs MGTX Comparison
MATV vs MGTX Comparison
Compare MATV & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATV
- MGTX
- Stock Information
- Founded
- MATV 1995
- MGTX 2015
- Country
- MATV United States
- MGTX United States
- Employees
- MATV N/A
- MGTX N/A
- Industry
- MATV Paper
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MATV Basic Materials
- MGTX Health Care
- Exchange
- MATV Nasdaq
- MGTX Nasdaq
- Market Cap
- MATV 673.6M
- MGTX 670.2M
- IPO Year
- MATV 1995
- MGTX N/A
- Fundamental
- Price
- MATV $12.36
- MGTX $7.33
- Analyst Decision
- MATV Strong Buy
- MGTX Strong Buy
- Analyst Count
- MATV 1
- MGTX 2
- Target Price
- MATV $10.00
- MGTX $24.00
- AVG Volume (30 Days)
- MATV 600.5K
- MGTX 276.6K
- Earning Date
- MATV 11-05-2025
- MGTX 11-12-2025
- Dividend Yield
- MATV 3.22%
- MGTX N/A
- EPS Growth
- MATV N/A
- MGTX N/A
- EPS
- MATV N/A
- MGTX N/A
- Revenue
- MATV $1,967,300,000.00
- MGTX $37,917,000.00
- Revenue This Year
- MATV $3.68
- MGTX $145.67
- Revenue Next Year
- MATV $2.82
- MGTX $167.61
- P/E Ratio
- MATV N/A
- MGTX N/A
- Revenue Growth
- MATV N/A
- MGTX 366.84
- 52 Week Low
- MATV $4.34
- MGTX $3.94
- 52 Week High
- MATV $19.96
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- MATV 66.98
- MGTX 42.80
- Support Level
- MATV $12.01
- MGTX $7.21
- Resistance Level
- MATV $12.51
- MGTX $7.91
- Average True Range (ATR)
- MATV 0.43
- MGTX 0.35
- MACD
- MATV -0.18
- MGTX -0.02
- Stochastic Oscillator
- MATV 51.85
- MGTX 19.89
About MATV Mativ Holdings Inc.
Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.